Clinical Trials Browser

Phase 1/2 × zegocractin × 90 days × Clear all

NCT04195347 2025-12-23

Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase

Phase 1/2 Recruiting

LymphoidOther hematologic neoplasm

Pancreatitis, Precursor Cell Lymphoblastic Leukemia-Lymphoma